Thursday, November 5, 2020
Regeneron hopes US will greenlight COVID-19 antibody drug soon | United Kingdom News
The treatment, which was given to President Trump, is under review by the US Food and Drug Administration. Regeneron Pharmaceuticals Inc said United States health regulators were doing a careful analysis of its experimental antibody cocktail to treat COVID-19 and that it was hopeful the drug could be authorised for emergency use in the country soon. The treatment, which was given to US 
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Threat actors are exploiting ProxyLogon and ProxyShell exploits in unpatched Microsoft Exchange Servers as part of an ongoing spam campaign
No comments:
Post a Comment